Latham & Watkins has advised Theramex on the deal.Theramex, a leading global pharmaceutical company specialising in women’s health, announced its licensing agreement with ObsEva SA, a…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
